Metastatic Castration Resistant Prostate Cancer (mCRPC) patients' experience with Radium-223 treatment in Japan - Supplementary Material
收藏Taylor & Francis Group2024-05-15 更新2026-04-16 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Metastatic_Castration_Resistant_Prostate_Cancer_mCRPC_patients_experience_with_Radium-223_treatment_in_Japan_-_Supplementary_Material/25070762/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table s1: Laboratory parametersSupplementary Table s2: Completion Rate of Ra-223 cyclesSupplementary Table s3: Information QuestionnaireSupplementary Table s4. Minimally important difference (MID) for PRO scales.
提供机构：
Nishimura, Kazuo; Akakura, Koichiro; Athene Ledesma, Dianne; Yokomizo, Akira; Nakamura, Motonobu; Komori, Tetsushi; Uemura, Hiroji; Kawakami, Satoru
创建时间：
2024-01-26
